Steffen Uffenorde
About Steffen Uffenorde
Steffen Uffenorde is a Senior Manager in Health Economics & Market Access at Boston Scientific and a Lecturer at Hochschule Fresenius, with extensive experience in the medical device industry and academia.
Current Roles at Hochschule Fresenius and Boston Scientific
Steffen Uffenorde currently serves as a Lecturer for Pharmacoeconomic Evaluation and Outcomes Research at Hochschule Fresenius in Wiesbaden, Hessen, Deutschland, a role he has held since 2022. Concurrently, he is the Senior Manager Health Economics & Market Access (HEMA), Rhythm Management EMEA at Boston Scientific in Ratingen, Nordrhein-Westfalen, Deutschland. He has been in this role since 2020.
Previous Experience in Health Economics and Public Policy
Steffen Uffenorde held the position of Public Policy Manager at BD in Heidelberg und Umgebung, Deutschland from 2018 to 2020. Prior to that, he worked briefly at Abbott as an Associate Manager Health Economics & Reimbursement in Eschborn. Additionally, he served as the Vice-Chair of the Digital Health Sector Working Group (SWG) at MedTech Europe for five months in 2018.
Academic Background
Steffen Uffenorde holds a Master of Arts (M.A.) in Health Care Management from Hochschule Osnabrück, University of Applied Sciences, where he studied from 2011 to 2014. He also earned a Bachelor of Arts (B.A.) in Health Care Business Management from Hochschule Fresenius, University of Applied Sciences, from 2008 to 2011.
Significant Contributions and Leadership Roles
Steffen Uffenorde has successfully led the application process for in- and outpatient codes for Dorsal Root Ganglion stimulation, a notable achievement in neuromodulation. His effective association work includes being Vice-Chair at the Digital Health Sector Working Group at Medtech and at the German Medical Technology Association (BVMed). Additionally, he has concluded framework agreements with major payer associations in Germany, enhancing the reimbursement landscape for medical devices.
Industry Involvement and Impact
Steffen Uffenorde serves as a primary interface with hospitals for benefit assessments of German medical devices under the German Social Insurance Code Volume V. His background in informing guideline decision-making processes within the medical device industry underscores his expertise in Health Economics and Market Access.